Amia Capital LLP Grifols Sa Transaction History

Amia Capital LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$14.07 - $17.3 $2.73 Million - $3.36 Million	-194,057 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $7.14 Million - $8.14 Million	-429,827 Reduced 68.9%	194,057 $3.37 Million
Q1 2021 May 17, 2021	SELL	$15.15 - $19.78 $5.53 Million - $7.22 Million	-365,203 Reduced 36.92%	623,884 $10.8 Million
Q4 2020 Feb 11, 2021	SELL	$16.86 - $19.67 $5.17 Million - $6.03 Million	-306,391 Reduced 23.65%	989,087 $18.2 Million
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $4.34 Million - $5.68 Million	-281,819 Reduced 17.87%	1,295,478 $22.5 Million

Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $4.13 Million - $4.86 Million	-226,559 Reduced 12.56%	1,577,297 $28.8 Million
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $5.76 Million - $9.07 Million	-354,050 Reduced 16.41%	1,803,856 $36.3 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $42.2 Million - $50.8 Million	2,157,906 New	2,157,906 $50.3 Million

149

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.48B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.